Astrazeneca Pharma India Ltd
Astrazeneca Pharma India Q1 FY19: Revenue ₹584.24 Cr
Q1 FY19 investor presentation: what the company reported on revenue, margins and projects.
Based on Astrazeneca Pharma India Ltd's Q1 FY19 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the presentation reports, not management guidance.
The short version
Total revenue for AstraZeneca Pharma India Ltd (FY 2017-2018) reported as ₹584.24 Crore (Page 8). The provided pages of the AstraZeneca Pharma India Limited presentation do not include specific quarterly financial figures such as EBITDA, operating margin, profit after tax (PAT), or year-on-year changes.
From Astrazeneca Pharma India Ltd's Q1 FY19 earnings-call transcript · updated 24 Sept 2026.
Revenue & Sales Performance
- Total revenue for AstraZeneca Pharma India Ltd (FY 2017-2018) reported as ₹584.24 Crore (Page 8).
- Partner contribution to sales: ₹29.95 Crore (Page 8).
- The Indian Pharmaceutical Market (IPM) size is ₹127,253 Crore, poised to grow at ~10% over next four years (Page 6).
- AstraZeneca is one of the fastest-growing major MNCs in the IPM with 64% contribution from growth platforms (Page 8).
- No explicit quarter-on-quarter or year-on-year revenue or volume change percentages are stated in the presentation.
2 more points management made on revenue & sales performance
Profitability & Margins
See what Astrazeneca Pharma India Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
Top-ranked in Pharmaceuticals & Biotechnology
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Astrazeneca Pharma India Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
Astrazeneca Pharma India Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹579 Cr, net profit ₹45 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Astrazeneca Pharma India Ltd's management said in earlier quarters
Frequently Asked Questions
What were Astrazeneca Pharma India Ltd Q1 FY19 results?
Total revenue for AstraZeneca Pharma India Ltd (FY 2017-2018) reported as ₹584.24 Crore (Page 8). The provided pages of the AstraZeneca Pharma India Limited presentation do not include specific quarterly financial figures such as EBITDA, operating margin, profit after tax (PAT), or year-on-year changes.
What is Astrazeneca Pharma India Ltd share price analysis?
Astrazeneca Pharma India Ltd currently shows a neutral. The stock trades at a P/E of 97.3 with a market cap of ₹16,879 Cr. Investors should review the full earnings analysis for detailed insights.
Is Astrazeneca Pharma India Ltd planning capital expenditure?
The presentation does not explicitly mention any capex, capacity expansion, or new plant/project details, including amounts, status, or timelines.
Keep Astrazeneca Pharma India Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.